Study To Determine Safety & Efficacy Of Autologous Human Platelet Lysate in Androgenetic Alopecia After Hair Transplant

Inclusion Criteria: * Male subjects, aged between 18 to 50 years (both inclusive) and in general good health * Subjects willing to refrain from other AGA treatments during the entire study duration * Subjects who are willing to give informed consent and adhere to the study protocol Exclusion Criteria: * Subjects aged \<18 or \> 50 years * Subjects with dermatological disorder of scalp that might interfere with study evaluation * Subjects on Anti-coagulant therapy * Subjects with clinically significant medical or psychiatric disease as determined by the investigator. * Subjects unwilling to or unable to comply with the study protocol. * Subjects taking concomitant therapy that might interfere with the study results in investigators opinion or participating in another trial in the past 30 days.